Liposomal Bupivacaine in Adductor Canal Blocks (ACB)
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether liposomal bupivacaine is superior to normal
bupivacaine in terms of providing better pain control postoperatively after total knee
arthroplasty.